Physician profile
John Thomas Evans
NPI 1083033286
$1,210.60
in general payments reported to CMS, 2019-2025
20 companies · $276 in 2025
The $276 reported for 2025 was more than what a typical Adult Health (Nurse Practitioner) provider received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $74.50 · 2022: $346 · 2023: $298 · 2024: $216 · 2025: $276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $790.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $790.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $276.98 | 2022-2023 | Freestyle Libre 3, Freestyle Libre 2 |
| Glaxosmithkline, LLC. | $142.76 | 2021-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $135.04 | 2022-2023 | Rybelsus |
| Abbvie INC. | $97.60 | 2022-2024 | |
| Astrazeneca Pharmaceuticals Lp | $96.76 | 2023-2025 | Breztri, Farxiga |
| Medtronic, INC. | $64.79 | 2025 | Symplicity G3, Minimed 780g |
| Lilly USA, LLC | $60.59 | 2023-2025 | Jardiance, Zepbound, Mounjaro |
| Pfizer INC. | $55.16 | 2023-2025 | |
| Astellas Pharma US INC | $49.29 | 2024-2025 | Veozah |
| Amgen INC. | $36.03 | 2024-2025 | Evenity, Prolia |
| Baxter Healthcare | $25.79 | 2022 | |
| Welch Allyn | $25.79 | 2021 | |
| Smith+Nephew, INC. | $21.84 | 2025 | Collagenase Santyl |
| Upsher-Smith Laboratories LLC | $21.64 | 2021 | |
| Radius Health, INC. | $21.50 | 2025 | Tymlos |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $20.33 | 2024 | |
| Phathom Pharmaceuticals, INC. | $19.80 | 2024 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $13.74 | 2022 | |
| Ucb, INC. | $13.31 | 2022 | |
| Merck Sharp & Dohme LLC | $11.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.